MedPath

Accelerated cTBS on Metabolic Dysfunction in People With Schizophrenia

Not Applicable
Recruiting
Conditions
Eating Behavior
Schizophrenia
Metabolic Disturbance
Transcranial Magnetic Stimulation
Interventions
Device: accelerated theta burst stimulation
Device: Sham stimulation
Registration Number
NCT05358899
Lead Sponsor
Central South University
Brief Summary

cTBS is a promising novel intervention, which has strong potential on moderating disease syndrome. However, the most effective pattern of the cTBS is still under debate. Therefore, the investigators designed this randomized controlled clinical trial to evaluate the efficacy and safety of accelerated cTBS, with 1800 stimulation per session, on intervention to metabolic side effects in individuals with schizophrenia.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients diagnosed with schizophrenia in accordance with DSM-5
  • BMI over 24
  • Accepting antipsychotics stable treatment for more then 2 months
Exclusion Criteria
  • Diagnosed with other mental disease in accordance with DSM-5
  • Comorbid with other severe physiological disease
  • Used antipsychotic, antidepressants, mood stabilizer, or other psychoactive substances before
  • Drug or alcohol abuse
  • Pregnant or lactating Contraindication to rTMS

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Real stimulationaccelerated theta burst stimulationParticipants in the real stimulation group will receive accelerated cTBS with 1800 stimulation per session for 10 consecutive days, 5 sessions per day with a gap at least one hour, 50 sessions in total. The stimulation will be conducted at left M1 area.
Sham stimulationSham stimulationParticipants in the sham stimulation group will receive the stimulation with coil vertical to the surface with other settings same as the real stimulation group.
Primary Outcome Measures
NameTimeMethod
Change of body weightfrom baseline to 6 weeks

the change of participants weight

Change of body mass indexfrom baseline to 6 weeks

the change of participants BMI

Secondary Outcome Measures
NameTimeMethod
Barrat impulsiveness scalefrom baseline to 6 weeks

four domains regarding impulsiveness, from 26-104 higher score means higher impulse.

Positive and Negative syndrome rating scalefrom baseline to 6 weeks

Positive and Negative syndrome rating scale, from 30-210, higher score means worse symptoms.

Three Factor Eating Questionnairefrom baseline to 6 weeks

three domain regarding eating behavior, from 0-51, higher score means better.

Food picture stimulation Event-related potentialsfrom baseline to 6 weeks

Several components of event-related potentials were analyzed regarding various cognitive processes. The data were analyzed using previously widely used pipelines to extract the characters of ERP components, for example, P3 and LPP, and compare its difference within groups and between groups through time. ERP analysis will be conducted using EEGLAB and FieldTrip in MATLAB, and statistic analysis will be conducted using R studio and SPSS.

Self-Control Scalefrom baseline to 6 weeks

five domains regarding self control ability, from 36-180 higher score means better self control.

Trial Locations

Locations (1)

Second Xiangya Hospital Central South University

🇨🇳

Changsha, Hunan, China

© Copyright 2025. All Rights Reserved by MedPath